Open AccessThyroid cancer in the era of endocrine disrupting compounds
Author(s) -
Cristina Preda,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
archive of clinical cases
Language(s) - English
Resource type - Journals
ISSN - 2360-6975
DOI - 10.22551/2021.33.0804.10188
Subject(s) - thyroid cancer , incidence (geometry) , endocrine system , medicine , thyroid , cancer , ultrasonography , thyroid tumors , cancer incidence , oncology , pathology , radiology , hormone , physics , optics
Thyroid cancer has the highest prevalence of all endocrine malignancies, accounting for 1–3% of all human tumors. The incidence of differentiated thyroid cancer has increased globally in the last 10-20 years, faster than that of any other cancer type. The rising incidence has been observed in females, young adults, and children. The possible explanation might be the new achievements in diagnostic procedures, as thyroid ultrasonography and elastography, plus molecular testing and tumoral markers. Even though “over diagnosis” cannot be excluded, the increased incidence for all tumor sizes may suggest that other factors, such as lifestyle changes and environmental influences may contribute to a real increase.